Smith & Nephew SNATS Income from Continuous Operations 2010-2025 | SNN

Smith & Nephew SNATS income from continuous operations for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.

  • Smith & Nephew SNATS annual income from continuous operations for 2024 was $0.412B, a 56.65% increase from 2023.
  • Smith & Nephew SNATS annual income from continuous operations for 2023 was $0.263B, a 17.94% increase from 2022.
  • Smith & Nephew SNATS annual income from continuous operations for 2022 was $0.223B, a 57.44% decline from 2021.

Smith & Nephew SNATS Income from Continuous Operations 2010-2025 | SNN

  • Smith & Nephew SNATS annual income from continuous operations for 2024 was $0.412B, a 56.65% increase from 2023.
  • Smith & Nephew SNATS annual income from continuous operations for 2023 was $0.263B, a 17.94% increase from 2022.
  • Smith & Nephew SNATS annual income from continuous operations for 2022 was $0.223B, a 57.44% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$233.7B
Boston Scientific (BSX)$152.8B
Stryker (SYK)$144.4B
EssilorLuxottica (ESLOY)$136.8B
Medtronic (MDT)$119.1B
Lonza Group Ag (LZAGY)$47.4B
Haleon (HLN)$42.9B
ResMed (RMD)$41.6B
GE HealthCare Technologies (GEHC)$32.9B
Agilent Technologies (A)$32.6B
Terumo (TRUMY)$27.5B
Koninklijke Philips (PHG)$25.8B
Insulet (PODD)$21.6B
Zimmer Biomet Holdings (ZBH)$19.6B
Baxter (BAX)$12.2B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$7.2B
Lantheus Holdings (LNTH)$3.9B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
Prestige Consumer Healthcare (PBH)$3.2B
Perrigo (PRGO)$3.1B
ICU Medical (ICUI)$2.8B
Haemonetics (HAE)$2.6B
LeMaitre Vascular (LMAT)$2.1B
AtriCure (ATRC)$1.8B
QuidelOrtho (QDEL)$1.6B
Green Thumb Industries (GTBIF)$1.5B
Curaleaf Holdings (CURLF)$1.4B